Catalyst
Slingshot members are tracking this event:
Esperion Therapeutics (ESPR) looking to release top-line data on Phase 3 lowering low density lipoprotein cholesterol LDL-C lower lowering efficacy studies on bempedoic acid by mid-2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ESPR | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 07, 2018
Occurred Source:
http://investor.esperion.com/releasedetail.cfm?ReleaseID=1059993
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ldl-c Lowering, Phase 3, Bempedoic Acid, Low-density Lipoprotein Cholesterol
